RadoNorm represented at European Lung Cancer Congress 2024

written by Nadja Železnik
03. Apr 2024
Categories: Conference

The 2024 European Lung Cancer Congress (ELCC), held in Prague, Czech Republic from March 20th to 23rd, was a gathering of experts and professionals dedicated to the research and treatment of thoracic cancers. Representing WP4 of RadoNorm, M. Bernabeu, an associated researcher, and L. Mezquita from the Hospital Clínic of Barcelona, actively participated in this forum of scientific exchange.

Bernabeu, with a background in basic research, sought to update himself in clinical and translational research. In his talk, Bernabeu delved into interdisciplinary areas of medical oncology such as oncologic radiology, epidemiology, genetics, and artificial intelligence. He highlighted the use of artificial intelligence in various fields of oncologic medicine and data treatment in the detection and treatment of lung cancer. He also emphasised the importance of studying molecular markers in lung cancer and their association with potential carcinogens like radon. Furthermore, he applied this knowledge to standardise and develop therapies targeted at these pathologies.

The event proved to be an enriching experience, fostering the sharing and discussion of scientific advancements with speakers and addressing key challenges in lung cancer research and treatment.


Related Posts

RadoNorm at the EGU 2024

RadoNorm was represented at the EGU 2024 General Assembly in the session “Radioactivity in the environment: opportunities for geosciences and implications for human health” on the 18th April 2024 in Vienna, Austria. The EGU General Assembly 2024 brings together...

RadoNorm at European Radiation Protection Week 2023

The 7th European Radiation Protection Week was held in Dublin, Ireland, and work from RadoNorm was featured in various talks and posters. The latest results from WP2 and WP5 were presented at the ALLIANCE general assembly. RadoNorm results were also presented in...